23 May 2013
Keywords: Russia, Pharma production, RusNano, Domain Associates
Article | 07 March 2012
Russian state nanotechnology corporation RusNano and Domain Associates, a US venture fund, are to invest $380 million each in the development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 March 2012
© 2013 thepharmaletter.com